The Clinical Diagnostics program offers clients unique insights into the competitive dynamics of the market, including coverage of sectors, such as molecular diagnostics, point-of-care testing, and in vitro diagnostics, from a regional and global perspective. Based on both quantitative and qualitative information, clients can leverage this information to stay abreast of challenges and trends, and to remain competitive and grow their businesses.
| Title |
Published |
|
North America; New Product Innovation Award - The Pressure Injury Prevention Industry
|
25 Oct 2017
|
|
North America; Visionary Innovation Leadership Award - EHR and Practice Management Systems in Oncology
|
24 Oct 2017
|
|
North America; Technology Innovation Award - Diagnostic Decision Support Systems for Pathology and Radiology
|
10 Oct 2017
|
2017 Customer Attitudes and Adoption Plans of Digital Pathology Technologies
A Voice of Customer Study to Compare Trends Between Current and Potential Adopters of Digital Pathology Platforms
|
25 Sep 2017
|
|
North America; New Product Innovation Award - Clinical Trials Data Management & Services Industry
|
01 Aug 2017
|
Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021
Rising Maternal Age, Improved Screening Algorithms Catering to Healthcare Payer Requirements, and Exploration of New Business Models Will Drive Market Growth
|
21 Jul 2017
|
US Oncology Diagnostics Market, Forecast to 2021
Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection
|
17 Jul 2017
|
|
Global; Company Of the Year Award - Clinical Diagnostic Lab It
|
06 Jul 2017
|
Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021
Innovation, Technology Integration, and New Customer Segments to Drive New Business Growth
|
06 Jul 2017
|
Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021
Data-driven Solutions and Co-development are Key Growth Drivers
|
30 Jun 2017
|
